Metagenomi, Inc.
MGX
$2.07
$0.136.70%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/18/2025
-
MarketBeat
2/16/2025
-
MarketBeat
2/11/2025
-
GuruFocus
2/11/2025
-
Globe Newswire
2/7/2025
-
Ticker Report
1/28/2025
-
SeekingAlpha
1/28/2025
-
Simply Wall St
1/27/2025
-
MarketBeat
1/25/2025
-
SeekingAlpha.com: All News
1/25/2025
-
Seeking Alpha - Healthcare
1/24/2025
-
Ticker Report
1/24/2025
-
MarketBeat
1/16/2025
-
GuruFocus
1/16/2025
-
The Fly
1/16/2025
-
Globe Newswire
1/15/2025
-
GuruFocus
1/15/2025
-
The Fly
1/15/2025
-
Globe Newswire
1/14/2025
-
Simply Wall St
1/14/2025
-
Ticker Report
1/8/2025
-
GuruFocus
1/8/2025
-
Globe Newswire
1/2/2025
-
Ticker Report
12/26/2024
-
MarketBeat
12/21/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 13, 2024
Period Date
Monday, September 30, 2024
Next Filing
(est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 871 4880
Address
5959 Horton Street
EmeryVille, CA 94608
EmeryVille, CA 94608
Country
Year Founded
Business Description
Sector
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company’s genome editing toolbox...
more
